Pfizer Recalls

2 recalls found for Pfizer. Check if any of your products are affected.

Health & Personal Care

HIGH

FDA DRUG

Hospira Sodium Bicarbonate Vial Recall for Sterility Concerns Affects 15,750 Vials

FDA-listed recall for Hospira brand 8.4% Sodium Bicarbonate Injection affecting 15,750 vials distributed nationwide. The liable lot LH2671, expiring 11/30/2026, is linked to a lack of assurance of sterility. Healthcare providers and patients should stop use and contact Pfizer for guidance.

Aug 4, 2025

Hospira

Lack of

Health & Personal Care

HIGH

FDA DRUG

Hospira Epinephrine Injection Vials Recalled for Lack of Sterility Assurance (2025)

Hospira recalls 49,620 vials of Epinephrine Injection, distributed nationwide in the United States. The recall, active since August 4, 2025, targets vials with NDC 0409-4933-05 and case NDC 0409-4933-10. The hazard is lack of assurance of sterility. Health professionals should stop using the product and contact Pfizer or a healthcare provider for guidance.

Aug 4, 2025

Epinephrine

Lack of

Brand Statistics

Total Recalls

Pages

Related Brands

Hospira Epinephrine